KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Intuitive Surgical (ISRG) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • Intuitive Surgical's Cash & Equivalents rose 6612.41% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 6612.41%. This contributed to the annual value of $3.4 billion for FY2025, which is 6612.41% up from last year.
  • Per Intuitive Surgical's latest filing, its Cash & Equivalents stood at $3.4 billion for Q4 2025, which was up 6612.41% from $2.8 billion recorded in Q3 2025.
  • In the past 5 years, Intuitive Surgical's Cash & Equivalents registered a high of $3.6 billion during Q3 2023, and its lowest value of $1.1 billion during Q1 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.3 billion (2023), whereas its average is $2.3 billion.
  • As far as peak fluctuations go, Intuitive Surgical's Cash & Equivalents soared by 13420.03% in 2023, and later crashed by 3208.5% in 2024.
  • Over the past 5 years, Intuitive Surgical's Cash & Equivalents (Quarter) stood at $1.3 billion in 2021, then increased by 22.49% to $1.6 billion in 2022, then surged by 75.19% to $2.8 billion in 2023, then decreased by 26.81% to $2.0 billion in 2024, then soared by 66.12% to $3.4 billion in 2025.
  • Its Cash & Equivalents stands at $3.4 billion for Q4 2025, versus $2.8 billion for Q3 2025 and $3.4 billion for Q2 2025.